483 Janssen Research & Development, Nov 2017

483 Janssen Research & Development, Nov 2017

Marcelo Mangalindan FDA$119.00 - Available Now

FDA investigators audited the Janssen Research & Development, - Spring House, PA, United States facility and issued inspectional observations (via FDA 483) on 21 Nov 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Nov 2017
  • Location: Spring House, United States
  • FEI: 3005548382
Add To Cart